Medical

SGS webinar on nitrosamine and genotoxic impurity management

Medical /

Geneva (October 6, 2025) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce a complimentary webinar, ‘Ensuring Patient Safety: Analytical Strategies for Nitrosamines & Genotoxic Impurities’, on October 21, 2025. Nitrosamines and other genotoxic impurities present a significant challenge to the pharmaceutical industry, as even trace levels can pose serious […]

SGS webinar on nitrosamine and genotoxic impurity management Read More »

SGS to showcase expertise and integrated drug development services at CPhI Frankfurt 2025

Medical /

Geneva (October 3, 2025) – SGS, the world’s leading testing, inspection and certification company, will attend CPhI Frankfurt 2025, taking place October 28–30 at Messe Frankfurt, Germany. This flagship event gathers pharmaceutical professionals worldwide to explore the latest trends and innovations in drug development, manufacturing and supply chain management. At stand 5.0A102 in the Contract

SGS to showcase expertise and integrated drug development services at CPhI Frankfurt 2025 Read More »

US FDA Ruling Confirms PFAS Fluoropolymers in Medical Devices Are Safe

Hardlines, Medical /

Geneva (September 4, 2025) – SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 125.25, reporting on the US Food and Drug Administration’s (FDA) review of per- and polyfluoroalkyl substances (PFAS) fluoropolymers in medical devices. The FDA has announced the results of a review finding no conclusive evidence of patient care issues

US FDA Ruling Confirms PFAS Fluoropolymers in Medical Devices Are Safe Read More »

DEHP Regulated in Certain Medical Devices in North Carolina, USA

Hardlines, Medical /

Geneva (August 21, 2025) – SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 119.25, summarizing North Carolina’s ban on di(2-ethylhexyl) phthalate (DEHP) in intravenous (IV) bags and tubing. SB 600 (session law 2025-60) was signed on July 3, 2025, regulating DEHP in IV solution containers and tubing. This amendment adds Article

DEHP Regulated in Certain Medical Devices in North Carolina, USA Read More »

GLP-1 Research and Regulatory Insights Webinar for the Nutra Industry

Medical /

SGS, the world’s leading testing, inspection and certification company, is delighted to present a complimentary webinar, ‘The GLP-1 craze decoded: current research and regulatory insights for the nutra industry,’ on February 27, 2025. Hormone-focused solutions for appetite modulation and weight management, such as GLP-1, are attracting significant attention within the nutraceutical industry. As market opportunities

GLP-1 Research and Regulatory Insights Webinar for the Nutra Industry Read More »

SGS introduces first commercial cell sorting service for the biopharmaceutical industry in Germany

Medical /

SGS, the world’s leading testing, inspection and certification company, is proud to announce the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry. This groundbreaking service leverages the advanced BD FACSAria™ Fusion system to support the development of advanced therapeutic medicinal products (ATMPs) and drive innovation in

SGS introduces first commercial cell sorting service for the biopharmaceutical industry in Germany Read More »

SGS Investigates MedTech Cybersecurity Challenges

Connectivity, Medical /

SGS, the world’s leading testing, inspection and certification company, has published a Consumer Compact article examining the dangers posed by cyberattacks on medical technologies (MedTech). Healthcare providers and patients are benefiting from an expanding range of digital technologies, which can enhance diagnosis, monitoring, treatment and care. Alongside these advances, the healthcare sector is increasingly facing

SGS Investigates MedTech Cybersecurity Challenges Read More »

SGS laboratory in Cork, Ireland, supports sustainability goals of pharmaceutical clients with recently awarded platinum My Green Lab certification

Medical /

SGS, the world’s leading testing, inspection and certification company, is proud to announce that its laboratory in Ringaskiddy, Cork, Ireland, has received platinum certification under the My Green Lab verification program. Pharmaceutical businesses looking to improve their sustainability credentials can now confidently partner with SGS, knowing they are working with a laboratory that is not

SGS laboratory in Cork, Ireland, supports sustainability goals of pharmaceutical clients with recently awarded platinum My Green Lab certification Read More »

SGS expands cutting-edge spray drug delivery testing capabilities in Belgium health science laboratory

Medical /

SGS, the world’s leading testing, inspection and certification company, has announced an expansion in its spray drug delivery testing capabilities at their laboratory in Wavre, Belgium. Utilizing the latest Malvern Spraytec system, SGS can now accurately measure droplet size in real-time during the spraying event, typically occurring within a fraction of a second. In line

SGS expands cutting-edge spray drug delivery testing capabilities in Belgium health science laboratory Read More »

DEHP Banned in Some Medical Devices in California

Hardlines, Medical /

SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 152.24 on California’s prohibition of Di-(2-ethylhexyl) phthalate (DEHP) in intravenous solution containers (IV bags) and IV tubing. AB 2300 was signed into law on September 25, 2024, making California the first US jurisdiction to restrict ortho-phthalates in medical devices. DEHP is an ortho-phthalate that

DEHP Banned in Some Medical Devices in California Read More »

Scroll to Top